Tokyo Tape
Sign in
← BrightPath Biotherapeutics

Annual report

4594.TEDINET S100VZBU
Period2024-04-01 → 2025-03-31
Filed2025-06-19
StandardJapan GAAP
ConsolidatedNo
Data checks13 of 13 passed
Key figures · 78
MetricValuePeriodScopeSource row
Revenue¥1m2024-04-01 → 2025-03-31StandaloneNet sales
Revenue¥72,0002023-04-01 → 2024-03-31StandaloneNet sales
Revenue¥5m2022-04-01 → 2023-03-31dStandaloneNet sales (5-year summary)
Revenue¥15m2021-04-01 → 2022-03-31dStandaloneNet sales (5-year summary)
Revenue¥3m2020-04-01 → 2021-03-31dStandaloneNet sales (5-year summary)
Operating income−¥1.2bn2024-04-01 → 2025-03-31StandaloneOperating income
Operating income−¥1.2bn2023-04-01 → 2024-03-31StandaloneOperating income
Ordinary income−¥1.1bn2024-04-01 → 2025-03-31StandaloneOrdinary income
Ordinary income−¥1.2bn2023-04-01 → 2024-03-31StandaloneOrdinary income
Ordinary income−¥1.5bn2022-04-01 → 2023-03-31dStandaloneOrdinary income loss (5-year summary)
Ordinary income−¥1.5bn2021-04-01 → 2022-03-31dStandaloneOrdinary income loss (5-year summary)
Ordinary income−¥1.7bn2020-04-01 → 2021-03-31dStandaloneOrdinary income loss (5-year summary)
Profit before tax−¥1.1bn2024-04-01 → 2025-03-31StandaloneIncome before income taxes
Profit before tax−¥1.2bn2023-04-01 → 2024-03-31StandaloneIncome before income taxes
Net income−¥1.2bn2024-04-01 → 2025-03-31StandaloneProfit loss
Net income−¥1.2bn2023-04-01 → 2024-03-31StandaloneProfit loss
Net income−¥1.5bn2022-04-01 → 2023-03-31dStandaloneNet income loss (5-year summary)
Net income−¥1.5bn2021-04-01 → 2022-03-31dStandaloneNet income loss (5-year summary)
Net income−¥1.7bn2020-04-01 → 2021-03-31dStandaloneNet income loss (5-year summary)
Total assets¥1.1bnat 2025-03-31StandaloneAssets
Total assets¥1.2bnat 2024-03-31StandaloneAssets
Total assets¥1.7bnat 2023-03-31dStandaloneTotal assets (5-year summary)
Total assets¥2.8bnat 2022-03-31dStandaloneTotal assets (5-year summary)
Total assets¥3.7bnat 2021-03-31dStandaloneTotal assets (5-year summary)
Total liabilities¥196mat 2025-03-31StandaloneLiabilities
Total liabilities¥251mat 2024-03-31StandaloneLiabilities
Net assets / equity¥925mat 2025-03-31StandaloneNet assets
Net assets / equity¥979mat 2024-03-31StandaloneNet assets
Net assets / equity¥1.6bnat 2023-03-31dStandaloneNet assets
Net assets / equity¥2.5bnat 2022-03-31dStandaloneNet assets (5-year summary)
Net assets / equity¥3.5bnat 2021-03-31dStandaloneNet assets (5-year summary)
Cash and deposits¥810mat 2025-03-31StandaloneCash and deposits
Cash and deposits¥1.1bnat 2024-03-31StandaloneCash and deposits
Cash & equivalents¥810mat 2025-03-31StandaloneCash and cash equivalents
Cash & equivalents¥1.1bnat 2024-03-31StandaloneCash and cash equivalents
Cash & equivalents¥1.5bnat 2023-03-31dStandaloneCash and cash equivalents
Cash & equivalents¥2.3bnat 2022-03-31dStandaloneCash and cash equivalents (5-year summary)
Cash & equivalents¥3.3bnat 2021-03-31dStandaloneCash and cash equivalents (5-year summary)
Operating cash flow−¥1.3bn2024-04-01 → 2025-03-31StandaloneNet cash provided by used in operating activities
Operating cash flow−¥1.2bn2023-04-01 → 2024-03-31StandaloneNet cash provided by used in operating activities
Operating cash flow−¥1.2bn2022-04-01 → 2023-03-31dStandaloneNet cash provided by used in operating activities (5-year summary)
Operating cash flow−¥1.5bn2021-04-01 → 2022-03-31dStandaloneNet cash provided by used in operating activities (5-year summary)
Operating cash flow−¥1.8bn2020-04-01 → 2021-03-31dStandaloneNet cash provided by used in operating activities (5-year summary)
Investing cash flow−¥1m2024-04-01 → 2025-03-31StandaloneNet cash provided by used in investment activities
Investing cash flow−¥8m2023-04-01 → 2024-03-31StandaloneNet cash provided by used in investment activities
Investing cash flow−¥2m2022-04-01 → 2023-03-31dStandaloneNet cash provided by used in investing activities (5-year summary)
Investing cash flow−¥18m2021-04-01 → 2022-03-31dStandaloneNet cash provided by used in investing activities (5-year summary)
Investing cash flow−¥36m2020-04-01 → 2021-03-31dStandaloneNet cash provided by used in investing activities (5-year summary)
Financing cash flow¥1.0bn2024-04-01 → 2025-03-31StandaloneNet cash provided by used in financing activities
Financing cash flow¥691m2023-04-01 → 2024-03-31StandaloneNet cash provided by used in financing activities
Financing cash flow¥432m2022-04-01 → 2023-03-31dStandaloneNet cash provided by used in financing activities (5-year summary)
Financing cash flow¥569m2021-04-01 → 2022-03-31dStandaloneNet cash provided by used in financing activities (5-year summary)
Financing cash flow¥2.1bn2020-04-01 → 2021-03-31dStandaloneNet cash provided by used in financing activities (5-year summary)
EPS (basic)¥-14.122024-04-01 → 2025-03-31StandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥-18.212023-04-01 → 2024-03-31StandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥-24.92022-04-01 → 2023-03-31dStandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥-28.552021-04-01 → 2022-03-31dStandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥-36.142020-04-01 → 2021-03-31dStandaloneBasic earnings loss per share (5-year summary)
Net assets per share¥9.98at 2025-03-31StandaloneNet assets per share (5-year summary)
Net assets per share¥13.52at 2024-03-31StandaloneNet assets per share (5-year summary)
Net assets per share¥24.6at 2023-03-31dStandaloneNet assets per share (5-year summary)
Net assets per share¥45.4at 2022-03-31dStandaloneNet assets per share (5-year summary)
Net assets per share¥69.1at 2021-03-31dStandaloneNet assets per share (5-year summary)
Equity ratio80.6%at 2025-03-31StandaloneEquity to asset ratio (5-year summary)
Equity ratio77.7%at 2024-03-31StandaloneEquity to asset ratio (5-year summary)
Equity ratio90.9%at 2023-03-31dStandaloneEquity to asset ratio (5-year summary)
Equity ratio90.5%at 2022-03-31dStandaloneEquity to asset ratio (5-year summary)
Equity ratio93.7%at 2021-03-31dStandaloneEquity to asset ratio (5-year summary)
Shares issued90,491,300at 2025-03-31StandaloneTotal number of issued shares (5-year summary)
Shares issued70,741,300at 2024-03-31StandaloneTotal number of issued shares (5-year summary)
Shares issued62,891,200at 2023-03-31dStandaloneTotal number of issued shares (5-year summary)
Shares issued55,253,100at 2022-03-31dStandaloneTotal number of issued shares (5-year summary)
Shares issued50,817,500at 2021-03-31dStandaloneTotal number of issued shares (5-year summary)
Employees24at 2025-03-31StandaloneNumber of employees
Employees24at 2024-03-31StandaloneNumber of employees
Employees32at 2023-03-31dStandaloneNumber of employees
Employees38at 2022-03-31dStandaloneNumber of employees
Employees44at 2021-03-31dStandaloneNumber of employees

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

All source rows · 742
ItemContextValueUnit
Other noiPrior1YearDuration_NonConsolidatedMember286000JPY
Other noiCurrentYearDuration_NonConsolidatedMember4000JPY
Non operating incomePrior1YearDuration_NonConsolidatedMember299000JPY
Non operating incomeCurrentYearDuration_NonConsolidatedMember17428000JPY
Foreign exchange losses noePrior1YearDuration_NonConsolidatedMember2659000JPY
Foreign exchange losses noeCurrentYearDuration_NonConsolidatedMember－JPY
Stock issuance cost noePrior1YearDuration_NonConsolidatedMember1399000JPY
Stock issuance cost noeCurrentYearDuration_NonConsolidatedMember4298000JPY
Other noePrior1YearDuration_NonConsolidatedMember90000JPY
Other noeCurrentYearDuration_NonConsolidatedMember90000JPY
Non operating expensesPrior1YearDuration_NonConsolidatedMember4149000JPY
Non operating expensesCurrentYearDuration_NonConsolidatedMember4388000JPY
Ordinary incomePrior1YearDuration_NonConsolidatedMember-1158929000JPY
Ordinary incomeCurrentYearDuration_NonConsolidatedMember-1147879000JPY
Impairment loss elPrior1YearDuration_NonConsolidatedMember7252000JPY
Impairment loss elCurrentYearDuration_NonConsolidatedMember1369000JPY
Other elPrior1YearDuration_NonConsolidatedMember0JPY
Other elCurrentYearDuration_NonConsolidatedMember0JPY
Extraordinary lossPrior1YearDuration_NonConsolidatedMember7252000JPY
Extraordinary lossCurrentYearDuration_NonConsolidatedMember1370000JPY
Income before income taxesPrior1YearDuration_NonConsolidatedMember-1166182000JPY
Income before income taxesCurrentYearDuration_NonConsolidatedMember-1149249000JPY
Income taxes currentPrior1YearDuration_NonConsolidatedMember1900000JPY
Income taxes currentCurrentYearDuration_NonConsolidatedMember1900000JPY
Income taxesPrior1YearDuration_NonConsolidatedMember1900000JPY
Income taxesCurrentYearDuration_NonConsolidatedMember1900000JPY
Profit lossPrior1YearDuration_NonConsolidatedMember-1168082000JPY
Profit lossCurrentYearDuration_NonConsolidatedMember-1151149000JPY
Net assetsPrior2YearInstant_NonConsolidatedMember_CapitalStockMember362185000JPY
Net assetsPrior2YearInstant_NonConsolidatedMember_LegalCapitalSurplusMember262185000JPY
Net assetsPrior2YearInstant_NonConsolidatedMember_OtherCapitalSurplusMember2408534000JPY
Net assetsPrior2YearInstant_NonConsolidatedMember_CapitalSurplusMember2670720000JPY
Net assetsPrior2YearInstant_NonConsolidatedMember_RetainedEarningsBroughtForwardMember-1485633000JPY
Net assetsPrior2YearInstant_NonConsolidatedMember_RetainedEarningsMember-1485633000JPY
Net assetsPrior2YearInstant_NonConsolidatedMember_TreasuryStockMember-0JPY
Net assetsPrior2YearInstant_NonConsolidatedMember_ShareholdersEquityMember1547272000JPY
Issuance of new sharesPrior1YearDuration_NonConsolidatedMember_CapitalStockMember288475000JPY
Issuance of new sharesPrior1YearDuration_NonConsolidatedMember_LegalCapitalSurplusMember288475000JPY
Issuance of new sharesPrior1YearDuration_NonConsolidatedMember_CapitalSurplusMember288475000JPY
Issuance of new sharesPrior1YearDuration_NonConsolidatedMember_ShareholdersEquityMember576950000JPY
Profit lossPrior1YearDuration_NonConsolidatedMember_RetainedEarningsBroughtForwardMember-1168082000JPY
Profit lossPrior1YearDuration_NonConsolidatedMember_RetainedEarningsMember-1168082000JPY
Profit lossPrior1YearDuration_NonConsolidatedMember_ShareholdersEquityMember-1168082000JPY
Purchase of treasury stockPrior1YearDuration_NonConsolidatedMember_ShareholdersEquityMember－JPY
Total changes of items during the periodPrior1YearDuration_NonConsolidatedMember_CapitalStockMember288475000JPY
Total changes of items during the periodPrior1YearDuration_NonConsolidatedMember_LegalCapitalSurplusMember288475000JPY
Total changes of items during the periodPrior1YearDuration_NonConsolidatedMember_OtherCapitalSurplusMember－JPY
Total changes of items during the periodPrior1YearDuration_NonConsolidatedMember_CapitalSurplusMember288475000JPY
Total changes of items during the periodPrior1YearDuration_NonConsolidatedMember_RetainedEarningsBroughtForwardMember-1168082000JPY
Total changes of items during the periodPrior1YearDuration_NonConsolidatedMember_RetainedEarningsMember-1168082000JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 13 of 13 passed
balance sheet identitynon_consolidated 2024-03-31pass
balance sheet identitynon_consolidated 2025-03-31pass rounding
dei present pass
period resolution pass
statement vs summary · net assetsnon_consolidated 2023-03-31pass
statement vs summary · net assetsnon_consolidated 2024-03-31pass
statement vs summary · net assetsnon_consolidated 2025-03-31pass
statement vs summary · operating cash flownon_consolidated 2023-04-01/2024-03-31pass
statement vs summary · operating cash flownon_consolidated 2024-04-01/2025-03-31pass
statement vs summary · revenuenon_consolidated 2023-04-01/2024-03-31pass
statement vs summary · revenuenon_consolidated 2024-04-01/2025-03-31pass
statement vs summary · total assetsnon_consolidated 2024-03-31pass
statement vs summary · total assetsnon_consolidated 2025-03-31pass